エノキサパリン原薬の世界市場：2025年

世界のエノキサパリン原薬の市場規模は、2024年の1億7,130万米ドルから2031年には2億8,708万米ドルに達すると予測され、2025年～2031年のCAGRは5.38%になるとみられています。

北米のエノキサパリン原薬の市場規模は、2024年の2,817万米ドルから2031年には4,023万米ドルに達すると予測され、2025年～2031年の予測期間中のCAGRは3.86%になるとみられています。

欧州のエノキサパリン原薬の市場規模は、2024年の9,434万米ドルから2031年には1億5,391万米ドルに達すると予測され、2025年から2031年の予測期間中のCAGRは4.68%になるとみられています。

アジア太平洋のエノキサパリン原薬の市場規模は、2024年の4,034万米ドルから2031年には7,775万米ドルに達すると予測され、2025年から2031年の予測期間中のCAGRは7.46%になるとみられています。

エノキサパリン原薬の主な世界的メーカーには、Hepalink、Yantai Dongcheng Pharmaceutical、Changzhou Qianhong Biopharma、Hebei Changshan Biochemical Pharmaceutical,、Hubei Enoray Biopharmaceutical（Tianjin Chasesun Pharmaceutical）、Chongqing Yino Pharma、Chengdu Baiyu Pharmaceutical、Haike Group、Jiangxi Haoran Bio-Pharma、Shandong Chenlong Pharmaceutical（Cisen Pharmaceutical）などがあります。2024年には、世界の上位5ベンダーが売上高の約69.88％を占めています。

調査範囲

当レポートは、エノキサパリン原薬の世界市場を定量的・定性的分析の両面から包括的に紹介し、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、エノキサパリン原薬に関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。

エノキサパリン原薬の市場規模・推計・予測は、2024年を基準年として、生産量/出荷量（Kg）および収益（100万米ドル）で提供し、2020年から2031年までの期間の履歴データと予測データを掲載しています。当レポートでは、世界のエノキサパリン原薬市場を包括的にセグメント化しています。製品タイプ別、用途別、参入企業別の地域別市場規模も掲載しています。

市場をより深く理解するために、競合情勢、主要競合企業のプロファイル、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。

当レポートは、エノキサパリン原薬メーカー、新規参入企業、本市場における産業チェーン関連企業に対し、市場全体および企業別、製品タイプ別、用途別、地域別のサブセグメントにおける収益、生産量、平均価格に関する情報を提供します。

目次

第1章 エノキサパリン原薬市場概要

• 製品定義
• エノキサパリン原薬、抗第Xa因子活性別
• エノキサパリン原薬、用途別
• 世界市場の成長見通し
• 前提と制限

第2章 メーカーによる市場競争

第3章 エノキサパリン原薬の生産、地域別

• 世界のエノキサパリン原薬の生産額予測：2020年対2024年対2031年、地域別
• 世界のエノキサパリン原薬の生産額：2020年～2031年、地域別
• 世界のエノキサパリン原薬の生産量予測：2020年対2024年対2031年、地域別
• 世界のエノキサパリン原薬の生産量：2020年～2031年、地域別
• 世界のエノキサパリン原薬の市場価格分析：2020年～2025年、地域別
• 世界のエノキサパリン原薬の生産量と価値、前年比成長率

第4章 エノキサパリン原薬の消費量、地域別

• 世界のエノキサパリン原薬の消費量予測：2020年対2024年対2031年、地域別
• 世界のエノキサパリン原薬の消費量：2020年～2031年、地域別
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第5章 抗Xa因子活性別セグメント

• 世界のエノキサパリン原薬の生産量、抗Xa因子活性別（2020年～2031年）
• 世界のエノキサパリン原薬の生産額、抗Xa因子活性別（2020年～2031年）
• 世界のエノキサパリン原薬の価格、抗Xa因子活性別（2020年～2031年）

第6章 用途別セグメント

• 世界のエノキサパリン原薬の生産量、用途別（2020年～2031年）
• 世界のエノキサパリン原薬の生産額、用途別（2020年～2031年）
• 世界のエノキサパリン原薬の価格、用途別（2020年～2031年）

第7章 主要企業のプロファイル

• Hepalink
• Yantai Dongcheng Pharmaceutical
• Changzhou Qianhong Biopharma
• Hebei Changshan Biochemical Pharmaceutical
• Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API
• Chongqing Yino Pharma
• Chengdu Baiyu Pharmaceutical
• Haike Group
• Jiangxi Haoran Bio-Pharma
• Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical)
• Stanex

第8章 産業チェーンと販売チャネルの分析

• エノキサパリン原薬産業チェーン分析
• エノキサパリン原薬原料供給分析
• エノキサパリン原薬の製造モードとプロセス分析
• エノキサパリン原薬の販売およびマーケティング
• エノキサパリン原薬顧客分析

第9章 エノキサパリン原薬市場力学

• エノキサパリン原薬業界の動向
• エノキサパリン原薬市場の促進要因
• エノキサパリン原薬市場の課題
• エノキサパリン原薬市場の抑制要因

第10章 調査結果と結論

第11章 調査手法とデータソース

List of Tables

• Table 1. Global Enoxaparin API Market Value by Anti-factor Xa Activity, (US$ Million) & (2024 VS 2031)
• Table 2. Global Enoxaparin API Market Value by Application, (US$ Million) & (2024 VS 2031)
• Table 3. Global Enoxaparin API Production by Manufacturers (2020-2025) & (Kg)
• Table 4. Global Enoxaparin API Production Market Share by Manufacturers (2020-2025)
• Table 5. Global Enoxaparin API Production Value by Manufacturers (2020-2025) & (US$ Million)
• Table 6. Global Enoxaparin API Production Value Share by Manufacturers (2020-2025)
• Table 7. Global Key Players of Enoxaparin API, Industry Ranking, 2024 VS 2025
• Table 8. Global Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Enoxaparin API as of 2024)
• Table 9. Global Market Enoxaparin API Average Price by Manufacturers (USD/Kg) & (2020-2025)
• Table 10. Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters
• Table 11. Global Key Manufacturers of Enoxaparin API, Product Type & Application
• Table 12. Global Key Manufacturers of Enoxaparin API, Date of Enter into This Industry
• Table 13. Global Enoxaparin API Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 14. Mergers & Acquisitions, Expansion Plans
• Table 15. Global Enoxaparin API Production Value Growth Rate by Region: 2020 VS 2024 VS 2031 (US$ Million)
• Table 16. Global Enoxaparin API Production Value (US$ Million) by Region (2020-2025)
• Table 17. Global Enoxaparin API Production Value Market Share by Region (2020-2025)
• Table 18. Global Enoxaparin API Production Value (US$ Million) Forecast by Region (2026-2031)
• Table 19. Global Enoxaparin API Production Value Market Share Forecast by Region (2026-2031)
• Table 20. Global Enoxaparin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
• Table 21. Global Enoxaparin API Production (Kg) by Region (2020-2025)
• Table 22. Global Enoxaparin API Production Market Share by Region (2020-2025)
• Table 23. Global Enoxaparin API Production (Kg) Forecast by Region (2026-2031)
• Table 24. Global Enoxaparin API Production Market Share Forecast by Region (2026-2031)
• Table 25. Global Enoxaparin API Market Average Price (USD/Kg) by Region (2020-2025)
• Table 26. Global Enoxaparin API Market Average Price (USD/Kg) by Region (2026-2031)
• Table 27. Global Enoxaparin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)
• Table 28. Global Enoxaparin API Consumption by Region (2020-2025) & (Kg)
• Table 29. Global Enoxaparin API Consumption Market Share by Region (2020-2025)
• Table 30. Global Enoxaparin API Forecasted Consumption by Region (2026-2031) & (Kg)
• Table 31. Global Enoxaparin API Forecasted Consumption Market Share by Region (2020-2025)
• Table 32. North America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
• Table 33. North America Enoxaparin API Consumption by Country (2020-2025) & (Kg)
• Table 34. North America Enoxaparin API Consumption by Country (2026-2031) & (Kg)
• Table 35. Europe Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
• Table 36. Europe Enoxaparin API Consumption by Country (2020-2025) & (Kg)
• Table 37. Europe Enoxaparin API Consumption by Country (2026-2031) & (Kg)
• Table 38. Asia Pacific Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
• Table 39. Asia Pacific Enoxaparin API Consumption by Region (2020-2025) & (Kg)
• Table 40. Asia Pacific Enoxaparin API Consumption by Region (2026-2031) & (Kg)
• Table 41. Latin America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
• Table 42. Latin America Enoxaparin API Consumption by Country (2020-2025) & (Kg)
• Table 43. Latin America Enoxaparin API Consumption by Country (2026-2031) & (Kg)
• Table 44. Global Enoxaparin API Production (Kg) by Anti-factor Xa Activity (2020-2025)
• Table 45. Global Enoxaparin API Production (Kg) by Anti-factor Xa Activity (2026-2031)
• Table 46. Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2020-2025)
• Table 47. Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2026-2031)
• Table 48. Global Enoxaparin API Production Value (US$ Million) by Anti-factor Xa Activity (2020-2025)
• Table 49. Global Enoxaparin API Production Value (US$ Million) by Anti-factor Xa Activity (2026-2031)
• Table 50. Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2020-2025)
• Table 51. Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2026-2031)
• Table 52. Global Enoxaparin API Price (USD/Kg) by Anti-factor Xa Activity (2020-2025)
• Table 53. Global Enoxaparin API Price (USD/Kg) by Anti-factor Xa Activity (2026-2031)
• Table 54. Global Enoxaparin API Production (Kg) by Application (2020-2025)
• Table 55. Global Enoxaparin API Production (Kg) by Application (2026-2031)
• Table 56. Global Enoxaparin API Production Market Share by Application (2020-2025)
• Table 57. Global Enoxaparin API Production Market Share by Application (2026-2031)
• Table 58. Global Enoxaparin API Production Value (US$ Million) by Application (2020-2025)
• Table 59. Global Enoxaparin API Production Value (US$ Million) by Application (2026-2031)
• Table 60. Global Enoxaparin API Production Value Market Share by Application (2020-2025)
• Table 61. Global Enoxaparin API Production Value Market Share by Application (2026-2031)
• Table 62. Global Enoxaparin API Price (USD/Kg) by Application (2020-2025)
• Table 63. Global Enoxaparin API Price (USD/Kg) by Application (2026-2031)
• Table 64. Hepalink Enoxaparin API Company Information
• Table 65. Hepalink Enoxaparin API Specification and Application
• Table 66. Hepalink Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 67. Hepalink Main Business and Markets Served
• Table 68. Hepalink Recent Developments/Updates
• Table 69. Yantai Dongcheng Pharmaceutical Enoxaparin API Company Information
• Table 70. Yantai Dongcheng Pharmaceutical Enoxaparin API Specification and Application
• Table 71. Yantai Dongcheng Pharmaceutical Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 72. Yantai Dongcheng Pharmaceutical Main Business and Markets Served
• Table 73. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
• Table 74. Changzhou Qianhong Biopharma Enoxaparin API Company Information
• Table 75. Changzhou Qianhong Biopharma Enoxaparin API Specification and Application
• Table 76. Changzhou Qianhong Biopharma Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 77. Changzhou Qianhong Biopharma Main Business and Markets Served
• Table 78. Changzhou Qianhong Biopharma Recent Developments/Updates
• Table 79. Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Company Information
• Table 80. Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Specification and Application
• Table 81. Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 82. Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served
• Table 83. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
• Table 84. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Company Information
• Table 85. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Specification and Application
• Table 86. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 87. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Main Business and Markets Served
• Table 88. Chongqing Yino Pharma Enoxaparin API Company Information
• Table 89. Chongqing Yino Pharma Enoxaparin API Specification and Application
• Table 90. Chongqing Yino Pharma Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 91. Chongqing Yino Pharma Main Business and Markets Served
• Table 92. Chengdu Baiyu Pharmaceutical Enoxaparin API Company Information
• Table 93. Chengdu Baiyu Pharmaceutical Enoxaparin API Specification and Application
• Table 94. Chengdu Baiyu Pharmaceutical Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 95. Chengdu Baiyu Pharmaceutical Main Business and Markets Served
• Table 96. Chengdu Baiyu Pharmaceutical Recent Developments/Updates
• Table 97. Haike Group Enoxaparin API Company Information
• Table 98. Haike Group Enoxaparin API Specification and Application
• Table 99. Haike Group Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 100. Haike Group Main Business and Markets Served
• Table 101. Jiangxi Haoran Bio-Pharma Enoxaparin API Company Information
• Table 102. Jiangxi Haoran Bio-Pharma Enoxaparin API Specification and Application
• Table 103. Jiangxi Haoran Bio-Pharma Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 104. Jiangxi Haoran Bio-Pharma Main Business and Markets Served
• Table 105. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Company Information
• Table 106. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Specification and Application
• Table 107. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 108. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Main Business and Markets Served
• Table 109. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Recent Developments/Updates
• Table 110. Stanex Enoxaparin API Company Information
• Table 111. Stanex Enoxaparin API Specification and Application
• Table 112. Stanex Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
• Table 113. Stanex Main Business and Markets Served
• Table 114. Key Raw Materials Lists
• Table 115. Raw Materials Key Suppliers Lists
• Table 116. Enoxaparin API Distributors List
• Table 117. Enoxaparin API Customers List
• Table 118. Enoxaparin API Market Trends
• Table 119. Enoxaparin API Market Drivers
• Table 120. Enoxaparin API Market Challenges
• Table 121. Enoxaparin API Market Restraints
• Table 122. Research Programs/Design for This Report
• Table 123. Key Data Information from Secondary Sources
• Table 124. Key Data Information from Primary Sources
• Table 125. Authors List of This Report

List of Figures

• Figure 1. Product Picture of Enoxaparin API
• Figure 2. Global Enoxaparin API Market Value by Anti-factor Xa Activity, (US$ Million) & (2024 VS 2031)
• Figure 3. Global Enoxaparin API Market Share by Anti-factor Xa Activity: 2024 VS 2031
• Figure 4. Enoxaparin Sodium Injection Preparation
• Figure 5. Global Enoxaparin API Market Value by Application, (US$ Million) & (2024 VS 2031)
• Figure 6. Global Enoxaparin API Market Share by Application: 2024 VS 2031
• Figure 7. Global Enoxaparin API Production Value (US$ Million), 2020 VS 2025 VS 2031
• Figure 8. Global Enoxaparin API Production Value (US$ Million) & (2020-2031)
• Figure 9. Global Enoxaparin API Production Capacity (Kg) & (2020-2031)
• Figure 10. Global Enoxaparin API Production (Kg) & (2020-2031)
• Figure 11. Global Enoxaparin API Average Price (USD/Kg) & (2020-2031)
• Figure 12. Enoxaparin API Report Years Considered
• Figure 13. Enoxaparin API Production Share by Manufacturers in 2024
• Figure 14. Enoxaparin API Production Value Share by Manufacturers in 2024
• Figure 15. Enoxaparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
• Figure 16. The Global 5 and 10 Largest Players: Market Share by Enoxaparin API Revenue in 2024
• Figure 17. Global Enoxaparin API Production Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million)
• Figure 18. Global Enoxaparin API Production Value Market Share by Region: 2020 VS 2024 VS 2031
• Figure 19. Global Enoxaparin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
• Figure 20. Global Enoxaparin API Production Market Share by Region: 2020 VS 2024 VS 2031
• Figure 21. North America Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031)
• Figure 22. Europe Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031)
• Figure 23. China Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031)
• Figure 24. India Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031)
• Figure 25. Global Enoxaparin API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)
• Figure 26. Global Enoxaparin API Consumption Market Share by Region: 2020 VS 2024 VS 2031
• Figure 27. North America Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 28. North America Enoxaparin API Consumption Market Share by Country (2020-2031)
• Figure 29. U.S. Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 30. Canada Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 31. Europe Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 32. Europe Enoxaparin API Consumption Market Share by Country (2020-2031)
• Figure 33. Germany Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 34. France Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 35. U.K. Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 36. Italy Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 37. Spain Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 38. Asia Pacific Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 39. Asia Pacific Enoxaparin API Consumption Market Share by Region (2026-2031)
• Figure 40. China Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 41. Japan Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 42. South Korea Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 43. Southeast Asia Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 44. India Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 45. Australia Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 46. Latin America Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 47. Latin America Enoxaparin API Consumption Market Share by Country (2020-2031)
• Figure 48. Mexico Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 49. Brazil Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 50. Middle East and Africa Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)
• Figure 51. Global Production Market Share of Enoxaparin API by Anti-factor Xa Activity (2020-2031)
• Figure 52. Global Production Value Market Share of Enoxaparin API by Anti-factor Xa Activity (2020-2031)
• Figure 53. Global Enoxaparin API Price (USD/Kg) by Anti-factor Xa Activity (2020-2031)
• Figure 54. Global Production Market Share of Enoxaparin API by Application (2020-2031)
• Figure 55. Global Production Value Market Share of Enoxaparin API by Application (2020-2031)
• Figure 56. Global Enoxaparin API Price (USD/Kg) by Application (2020-2031)
• Figure 57. Enoxaparin API Value Chain
• Figure 58. Heparin Sodium Production Process
• Figure 59. Enoxaparin API Production Process
• Figure 60. Channels of Distribution (Direct Vs Distribution)
• Figure 61. Bottom-up and Top-down Approaches for This Report
• Figure 62. Data Triangulation

Global Enoxaparin API market size in terms of revenue is projected to reach 287.08 million USD by 2031 from 171.30 million USD in 2024, with a CAGR 5.38% during 2025-2031.

North America market for Enoxaparin API is estimated to increase from 28.17 million USD in 2024 to reach 40.23 million USD by 2031, at a CAGR of 3.86% during the forecast period of 2025 through 2031.

Europe market for Enoxaparin API is estimated to increase from 94.34 million USD in 2024 to reach 153.91 million USD by 2031, at a CAGR of 4.68% during the forecast period of 2025 through 2031.

Asia-Pacific market for Enoxaparin API is estimated to increase from 40.34 million USD in 2024 to reach 77.75 million USD by 2031, at a CAGR of 7.46% during the forecast period of 2025 through 2031.

The major global manufacturers of Enoxaparin API include Hepalink, Yantai Dongcheng Pharmaceutical, Changzhou Qianhong Biopharma, Hebei Changshan Biochemical Pharmaceutical, Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical), Chongqing Yino Pharma, Chengdu Baiyu Pharmaceutical, Haike Group, Jiangxi Haoran Bio-Pharma, Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical), etc. In 2024, the world's top five vendors accounted for approximately 69.88% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enoxaparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin API.

The Enoxaparin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enoxaparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enoxaparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Hepalink
• Yantai Dongcheng Pharmaceutical
• Changzhou Qianhong Biopharma
• Hebei Changshan Biochemical Pharmaceutical
• Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical)
• Chongqing Yino Pharma
• Chengdu Baiyu Pharmaceutical
• Haike Group
• Jiangxi Haoran Bio-Pharma
• Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical)
• Stanex

Segment by Anti-factor Xa Activity

• Above 100 IU/mg
• Below 100 IU/mg

Segment by Application

• 0.2ml:2000IU
• 0.4ml:4000IU
• 0.6ml:6000IU
• 0.8ml:8000IU
• 1ml:10000IU
• Others

Production by Region

• North America
• Europe
• China
• India

Consumption by Region

• North America
• U.S.
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Latin America
• Mexico
• Brazil
• Middle East & Africa

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Enoxaparin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Enoxaparin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Enoxaparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Enoxaparin API Market Overview

• 1.1 Product Definition
• 1.2 Enoxaparin API by Anti-factor Xa Activity
  • 1.2.1 Global Enoxaparin API Market Value Growth Rate Analysis by Anti-factor Xa Activity: 2024 VS 2031
  • 1.2.2 Above 100 IU/mg
  • 1.2.3 Below 100 IU/mg
• 1.3 Enoxaparin API by Application
  • 1.3.1 Global Enoxaparin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
  • 1.3.2 0.2ml:2000IU
  • 1.3.3 0.4ml:4000IU
  • 1.3.4 0.6ml:6000IU
  • 1.3.5 0.8ml:8000IU
  • 1.3.6 1ml:10000IU
  • 1.3.7 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 1.4.2 Global Enoxaparin API Production Capacity Estimates and Forecasts (2020-2031)
  • 1.4.3 Global Enoxaparin API Production Estimates and Forecasts (2020-2031)
  • 1.4.4 Global Enoxaparin API Market Average Price Estimates and Forecasts (2020-2031)
• 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

• 2.1 Global Enoxaparin API Production Market Share by Manufacturers (2020-2025)
• 2.2 Global Enoxaparin API Production Value Market Share by Manufacturers (2020-2025)
• 2.3 Global Key Players of Enoxaparin API, Industry Ranking, 2023 VS 2024
• 2.4 Global Enoxaparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.5 Global Enoxaparin API Average Price by Manufacturers (2020-2025)
• 2.6 Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters
• 2.7 Global Key Manufacturers of Enoxaparin API, Product Type & Application
• 2.8 Global Key Manufacturers of Enoxaparin API, Date of Enter into This Industry
• 2.9 Global Enoxaparin API Market Competitive Situation and Trends
  • 2.9.1 Global Enoxaparin API Market Concentration Rate
  • 2.9.2 Global 5 and 10 Largest Enoxaparin API Players Market Share by Revenue
• 2.10 Mergers & Acquisitions, Expansion

3 Enoxaparin API Production by Region

• 3.1 Global Enoxaparin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.2 Global Enoxaparin API Production Value by Region (2020-2031)
  • 3.2.1 Global Enoxaparin API Production Value Market Share by Region (2020-2025)
  • 3.2.2 Global Forecasted Production Value of Enoxaparin API by Region (2026-2031)
• 3.3 Global Enoxaparin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.4 Global Enoxaparin API Production by Region (2020-2031)
  • 3.4.1 Global Enoxaparin API Production Market Share by Region (2020-2025)
  • 3.4.2 Global Forecasted Production of Enoxaparin API by Region (2026-2031)
• 3.5 Global Enoxaparin API Market Price Analysis by Region (2020-2025)
• 3.6 Global Enoxaparin API Production and Value, Year-over-Year Growth
  • 3.6.1 North America Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 3.6.2 Europe Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 3.6.3 China Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
  • 3.6.4 India Enoxaparin API Production Value Estimates and Forecasts (2020-2031)

4 Enoxaparin API Consumption by Region

• 4.1 Global Enoxaparin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 4.2 Global Enoxaparin API Consumption by Region (2020-2031)
  • 4.2.1 Global Enoxaparin API Consumption by Region (2020-2031)
  • 4.2.2 Global Enoxaparin API Forecasted Consumption by Region (2026-2031)
• 4.3 North America
  • 4.3.1 North America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.3.2 North America Enoxaparin API Consumption by Country (2020-2031)
  • 4.3.3 U.S.
  • 4.3.4 Canada
• 4.4 Europe
  • 4.4.1 Europe Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.4.2 Europe Enoxaparin API Consumption by Country (2020-2031)
  • 4.4.3 Germany
  • 4.4.4 France
  • 4.4.5 U.K.
  • 4.4.6 Italy
  • 4.4.7 Spain
• 4.5 Asia Pacific
  • 4.5.1 Asia Pacific Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.5.2 Asia Pacific Enoxaparin API Consumption by Region (2020-2031)
  • 4.5.3 China
  • 4.5.4 Japan
  • 4.5.5 South Korea
  • 4.5.6 Southeast Asia
  • 4.5.7 India
  • 4.5.8 Australia
• 4.6 Latin America
  • 4.6.1 Latin America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.6.2 Latin America Enoxaparin API Consumption by Country (2020-2031)
  • 4.6.3 Mexico
  • 4.6.4 Brazil
• 4.7 Middle East and Africa

5 Segment by Anti-factor Xa Activity

• 5.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2031)
  • 5.1.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2025)
  • 5.1.2 Global Enoxaparin API Production by Anti-factor Xa Activity (2026-2031)
  • 5.1.3 Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2020-2031)
• 5.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2031)
  • 5.2.1 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2025)
  • 5.2.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2026-2031)
  • 5.2.3 Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2020-2031)
• 5.3 Global Enoxaparin API Price by Anti-factor Xa Activity (2020-2031)

6 Segment by Application

• 6.1 Global Enoxaparin API Production by Application (2020-2031)
  • 6.1.1 Global Enoxaparin API Production by Application (2020-2025)
  • 6.1.2 Global Enoxaparin API Production by Application (2026-2031)
  • 6.1.3 Global Enoxaparin API Production Market Share by Application (2020-2031)
• 6.2 Global Enoxaparin API Production Value by Application (2020-2031)
  • 6.2.1 Global Enoxaparin API Production Value by Application (2020-2025)
  • 6.2.2 Global Enoxaparin API Production Value by Application (2026-2031)
  • 6.2.3 Global Enoxaparin API Production Value Market Share by Application (2020-2031)
• 6.3 Global Enoxaparin API Price by Application (2020-2031)

7 Key Companies Profiled

• 7.1 Hepalink
  • 7.1.1 Hepalink Enoxaparin API Company Information
  • 7.1.2 Hepalink Enoxaparin API Product Portfolio
  • 7.1.3 Hepalink Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.1.4 Hepalink Main Business and Markets Served
  • 7.1.5 Hepalink Recent Developments/Updates
• 7.2 Yantai Dongcheng Pharmaceutical
  • 7.2.1 Yantai Dongcheng Pharmaceutical Enoxaparin API Company Information
  • 7.2.2 Yantai Dongcheng Pharmaceutical Enoxaparin API Product Portfolio
  • 7.2.3 Yantai Dongcheng Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.2.4 Yantai Dongcheng Pharmaceutical Main Business and Markets Served
  • 7.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
• 7.3 Changzhou Qianhong Biopharma
  • 7.3.1 Changzhou Qianhong Biopharma Enoxaparin API Company Information
  • 7.3.2 Changzhou Qianhong Biopharma Enoxaparin API Product Portfolio
  • 7.3.3 Changzhou Qianhong Biopharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.3.4 Changzhou Qianhong Biopharma Main Business and Markets Served
  • 7.3.5 Changzhou Qianhong Biopharma Recent Developments/Updates
• 7.4 Hebei Changshan Biochemical Pharmaceutical
  • 7.4.1 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Company Information
  • 7.4.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Product Portfolio
  • 7.4.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.4.4 Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served
  • 7.4.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
• 7.5 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical)
  • 7.5.1 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Company Information
  • 7.5.2 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Product Portfolio
  • 7.5.3 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.5.4 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Main Business and Markets Served
• 7.6 Chongqing Yino Pharma
  • 7.6.1 Chongqing Yino Pharma Enoxaparin API Company Information
  • 7.6.2 Chongqing Yino Pharma Enoxaparin API Product Portfolio
  • 7.6.3 Chongqing Yino Pharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.6.4 Chongqing Yino Pharma Main Business and Markets Served
• 7.7 Chengdu Baiyu Pharmaceutical
  • 7.7.1 Chengdu Baiyu Pharmaceutical Enoxaparin API Company Information
  • 7.7.2 Chengdu Baiyu Pharmaceutical Enoxaparin API Product Portfolio
  • 7.7.3 Chengdu Baiyu Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.7.4 Chengdu Baiyu Pharmaceutical Main Business and Markets Served
  • 7.7.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
• 7.8 Haike Group
  • 7.8.1 Haike Group Enoxaparin API Company Information
  • 7.8.2 Haike Group Enoxaparin API Product Portfolio
  • 7.8.3 Haike Group Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.8.4 Haike Group Main Business and Markets Served
• 7.9 Jiangxi Haoran Bio-Pharma
  • 7.9.1 Jiangxi Haoran Bio-Pharma Enoxaparin API Company Information
  • 7.9.2 Jiangxi Haoran Bio-Pharma Enoxaparin API Product Portfolio
  • 7.9.3 Jiangxi Haoran Bio-Pharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.9.4 Jiangxi Haoran Bio-Pharma Main Business and Markets Served
• 7.10 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical)
  • 7.10.1 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Company Information
  • 7.10.2 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Product Portfolio
  • 7.10.3 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.10.4 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Main Business and Markets Served
  • 7.10.5 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Recent Developments/Updates
• 7.11 Stanex
  • 7.11.1 Stanex Enoxaparin API Company Information
  • 7.11.2 Stanex Enoxaparin API Product Portfolio
  • 7.11.3 Stanex Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
  • 7.11.4 Stanex Main Business and Markets Served

8 Industry Chain and Sales Channels Analysis

• 8.1 Enoxaparin API Industry Chain Analysis
• 8.2 Enoxaparin API Raw Material Supply Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 Enoxaparin API Production Mode & Process Analysis
• 8.4 Enoxaparin API Sales and Marketing
  • 8.4.1 Enoxaparin API Sales Channels
  • 8.4.2 Enoxaparin API Distributors
• 8.5 Enoxaparin API Customer Analysis

9 Enoxaparin API Market Dynamics

• 9.1 Enoxaparin API Industry Trends
• 9.2 Enoxaparin API Market Drivers
• 9.3 Enoxaparin API Market Challenges
• 9.4 Enoxaparin API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

• 11.1 Methodology/Research Approach
  • 11.1.1 Research Programs/Design
  • 11.1.2 Market Size Estimation
  • 11.1.3 Market Breakdown and Data Triangulation
• 11.2 Data Source
  • 11.2.1 Secondary Sources
  • 11.2.2 Primary Sources
• 11.3 Author List
• 11.4 Disclaimer 111